1. The paradigm shift from <scp>NAFLD</scp> to <scp>MAFLD</scp> : A global primary care viewpoint
- Author
-
Taghreed M. Farahat, Mehmet Ungan, Josep Vilaseca, Jacqueline Ponzo, Pramendra Prasad Gupta, Andrew D. Schreiner, Wadeia Al Sharief, Kelly Casler, Tafat Abdelkader, Ludovico Abenavoli, Fatima‐Zohra Mchich Alami, Mattias Ekstedt, Muntadar S. Jabir, Matthew J. Armstrong, Mona H. Osman, Johannes Wiegand, Dina Attia, Veronique Verhoeven, Ashraf Abdul Qayoum Amir, Nagwa N. Hegazy, Emmanuel A. Tsochatzis, Yasser Fouad, Helena Cortez‐Pinto, and Repositório da Universidade de Lisboa
- Subjects
Primary Health Care ,Hepatology ,Non-alcoholic Fatty Liver Disease ,education ,Disease Progression ,Humans ,Human medicine - Abstract
© 2022 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd., Half of the global overweight/obese adult population have metabolic-dysfunction-associated fatty liver disease (MAFLD), with prevalence rising, even among non-obese individuals. This increase is observed globally and mostly in low- and low-middleincome countries of Africa, Asia and South America and represents a great worldwide burden on healthcare expenditures. Lifestyle changes and a healthy diet are still the cornerstone in the clinical management of these patients as approved medications are presently lacking.
- Published
- 2022